Updated: J&J builds out global manufacturing capacity for CAR-T Carvyktinews2023-10-19T15:10:10+00:00October 19th, 2023|Endpoints News|
Beam cuts 20% of staff, looks to partner on base-edited CAR-T one month after dosing first patientnews2023-10-19T14:58:47+00:00October 19th, 2023|Endpoints News|
Chan-Zuckerberg’s new center in New York; Endeavor buys rights to ADC; Basilea acquires antifungalnews2023-10-19T14:52:36+00:00October 19th, 2023|Endpoints News|
Walgreens’ Sashi Moodley on the retail pharmacy’s value-based care strategynews2023-10-19T14:01:29+00:00October 19th, 2023|Endpoints News|
First AI-designed drugs fall short in the clinic, following years of hypenews2023-10-19T13:37:17+00:00October 19th, 2023|Endpoints News|
Illinois man accused of insider trading after making nearly $100K on Pfizer-Array buyout based on spouse’s informationnews2023-10-19T10:54:29+00:00October 19th, 2023|Endpoints News|
Roche makes four pipeline changes on back of trial failures, but sees path ahead for three therapiesnews2023-10-19T10:22:17+00:00October 19th, 2023|Endpoints News|
Pfizer sets Paxlovid price at $1,390 for five-day coursenews2023-10-18T21:26:02+00:00October 18th, 2023|Endpoints News|
Emergent recruits NFL Hall of Famer for Narcan opioid overdose campaignnews2023-10-18T19:09:32+00:00October 18th, 2023|Endpoints News|
EMA looks into falsified Ozempic with German and Austrian originsnews2023-10-18T17:27:57+00:00October 18th, 2023|Endpoints News|
